Medical/Pharmaceuticals

Taiyo Corporation Introducing OPELAIII "Subscription Style" Rental Purchase Plan

Once subscription ends, the units can be redistributed as used equipment to countries with strong demands and thereby meet SDGs requirement TOKYO, April 27, 2022 /PRNewswire/ -- Taiyo Corporation (Headquarter: Tokyo, Japan / President: Mariko Koizumi), the manufacturer of Wearable Surgical Light...

2022-04-27 06:00 1793

Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia

NEW YORK and HONG KONG, April 27, 2022 /PRNewswire/ -- Treadwell Therapeutics, a clinical-stage biotechnology company developing novel medicines for unmet needs in cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to CFI-400945, a first in...

2022-04-27 04:30 1886

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV ...

2022-04-27 00:09 2319

Seegene unveils world's first commercialized '3 Ct' PCR assay

* Provides Ct value of three targets in one channel; '3 Ct' PCR assay to launch in H1 * "Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, MuDT™ * '3 Ct' to lay foundation for automated syndromic testing ...

2022-04-26 20:32 1693

PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study

DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the positive results from the GLP toxicology study of PMC-403, the Company's novel TIE2-...

2022-04-26 20:30 1260

NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING

HEIDELBERG, Germany, and CAMBRIDGE, Mass., April 26, 2022 /PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) e...

2022-04-26 20:00 1224

PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology

DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the appointment ofQuan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Adviso...

2022-04-26 20:00 1310

SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform

BOSTON and LAUSANNE, Switzerland, April 26, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, has reached the milestone of one million genomic profiles analyzed by its SOPHiA DDM™ Platform, securing its position as one of the largest knowledge sharing platform...

2022-04-26 19:57 1676

Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu

NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific community in-depth details about its platform via thepublica...

2022-04-26 19:30 1631

Two Outstanding Hong Kong Startups Named Top Winners of Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022

Securing Investment Opportunity of Up to USD4 Million Healthcare and Sustainability become popular sectors among startups HONG KONG, April 26, 2022 /PRNewswire/ -- Alibaba Entrepreneurs Fund/HSBC JUMPSTARTER 2022 Global Pitch Competition ("JUMPSTARTER 2022") has concluded its Grand Finale. After...

2022-04-26 17:12 2693

SonoScape S-Fetus 4.0 Release to Simplify Sonography Process

SHENZHEN, China, April 26, 2022 /PRNewswire/ -- SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company's flagship ultrasound product offering. This technical breakthrough marks S-Fetus 4.0 as the globally first smart obstetric screening tech...

2022-04-26 17:06 1937

Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress

LACHEN, Switzerland, April 26, 2022 /PRNewswire/ -- As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place fromMay 8 to 11, 2022. This continue...

2022-04-26 16:00 1690

Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.

- Trusted by 4.5 Million Monthly Users Worldwide - TOKYO and SINGAPORE, April 26, 2022 /PRNewswire/ -- Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," has launched inthe United States an "AI-powered symptom checker" ( https://ubiehealth.com

2022-04-26 14:00 1365

The First International COVID-19 Testing Standard Released

BEIJING, April 26, 2022 /PRNewswire/ -- According to the State Administration for Market Regulation, the International Organization for Standardization (ISO) released the first international standard specifically for the detection of SARS-CoV-2, the virus that causes COVID-19. On April 19, ISO i...

2022-04-26 13:02 1226

Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Tracking hormonal pathways linking stress with reproductive dysfunction and failure

 SINGAPORE, April 26, 2022 /PRNewswire/ -- Advanced insights into the potential impacts of stress on human reproductive health will be reported at the 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) starting on Thursday. The Congress will hear of profound interaction betw...

2022-04-26 12:20 1757

Adge Pharmaceuticals partners with Cyan Bio of Korea to advance treatments for rare pediatric diseases in Asian countries

MOUNTAIN VIEW, Calif., April 26, 2022 /PRNewswire/ -- Adge Pharmaceuticals ("Adge") has entered into a license agreement with Korea-based Cyan Bio, Inc. ("Cyan"). Cyan will receive exclusive rights for commercialization of elocalcitol in key territories inAsia for the treatment of the Rett Syndro...

2022-04-26 07:00 1310

SOFWAVE™ Is This Year's NewBeauty Award Winner!

"Best Latest in Ultrasound" SAN CLEMENTE, Calif., April 25, 2022 /PRNewswire/ -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, proudly announces that Sofwave™, the latest game-changing ultrasound technolo...

2022-04-25 20:00 1771

DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions

Radiology Online Learning Centre from DetectedX – Available as Part of the GE Healthcare Clinical Education Program – Has Shown a 34% Improvement in the Accuracy of Diagnosing Difficult Cases SYDNEY, April 25, 2022 /PRNewswire/ -- Fostering global excellence in diagnostic accuracy, DetectedX and...

2022-04-25 20:00 1667

ITRI Named a Double Winner at Edison Awards 2022

HSINCHU, April 25, 2022 /PRNewswire/ -- The Edison Awards , one of the world's most revered innovation awards, announced the 2022 winners onApril 21 in Fort Myers, FL. At this year's program,ITRI won two awards in the sci...

2022-04-25 18:15 1594

WuXi AppTec Reports Record First-Quarter In 2022

Revenue Up 71.2% Year-Over-Year to RMB8,474 Million Net Profit Attributable to Owners of the Company Up 9.5% Year-Over-Year to RMB1,643 Million Diluted Earnings Per Share (EPS) Up 3.9% Year-Over-Year to RMB0.53 Adjusted Non-IFRS[1] Net Profit Attributable to Owners of the Company Up 85.8% Ye...

2022-04-25 17:52 2497
1 ... 255256257258259260261 ... 578